1 / 8

Steven Shoptaw, PhD UCLA Department of Family Medicine

a Draft Package of Interventions for ensuring access to HIV Prevention, Treatment, and Care for Stimulant Users. Steven Shoptaw, PhD UCLA Department of Family Medicine Center for Behavioral and Addiction Medicine sshoptaw@mednet.ucla.edu. Overview of Document. Introduction/rationale

guy
Télécharger la présentation

Steven Shoptaw, PhD UCLA Department of Family Medicine

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. a Draft Package of Interventions for ensuring access to HIV Prevention, Treatment, and Care for Stimulant Users Steven Shoptaw, PhD UCLA Department of Family Medicine Center for Behavioral and Addiction Medicine sshoptaw@mednet.ucla.edu

  2. Overview of Document • Introduction/rationale • Background • Intervention package for HIV prevention, treatment and care for people who use stimulant • Target-setting process • Annexes: • Methodology for developing document • Framework for setting indicators and targets

  3. Right off: • Page 1: Stimulant users are a diverse group and importance of ensuring access to HIV prevention, treatment and care can be different across groups • Type of stimulant used • Route of administration • Contexts of stimulant use • Each of these factors introduce important and unique ways in which access is limited for stimulant users

  4. Criteria applied to review of interventions • Must focus on HIV or AIDS • Include an outcome evaluation • Target stimulant users • use within last 12 months • crack/cocaine and or ATS as the primary drug • in mixed samples: >50% report stimulant use, regardless of route of administration • Report 1 or more HIV outcomes • HIV-related sexual behaviours (# sex partners, condom use) • HIV-related drug use behaviours (injection use, sex for drug) • HIV biomarkers (VL, CD4, incidence or prevalence)

  5. Package of Interventions • HIV testing and counselling • Antiretroviral therapy • Drug dependence treatment • Condom distribution programmes • Needle and syringe programmes for those who inject stimulants • Behavioural interventions aimed to reduce HIV transmission • Screening, prevention, and treatment of HCV, HBV, STIs, and TB • Targeted information, education, communication programmes • Voluntary medical male circumcision

  6. Next steps • Electronic consultation • Revised draft of technical guidelines • Circulate to advisors • Review of feedback with integration of comments • Preparation of document for distribution

  7. Project timeline Compile & synthesize evidence and draft guide Conduct lit search Electronic consultation Integrate feedback Integrate feedback Global Expert Meeting • Mar - Jun • Sept • Oct • July • Nov • Dec • Jan • Feb • Jan-end • Sep-Oct • Nov-Dec Production and comments Electronic consultation AIDS 2012 meeting Consensus, Guidance & approval Document production & release

  8. Comments/questions Steve Shoptaw PhD sshoptaw@mednet.ucla.edu

More Related